Mark Plavsic

Insider Reports History

Entity
Individual
Location
C/O Fate Therapeutics, Inc., 3535 General Atomics Court Ste 200, San Diego, California
Signature
/s/ Julie Feder, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Plavsic:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aura Biosciences, Inc. Chief Technology Officer Common Stock 129K $982K $7.64 Mar 15, 2024 Direct
FATE THERAPEUTICS INC Chief Technical Officer Common Stock 124K $541K $4.37 Jan 10, 2023 Direct

Insider Reports Filed by Mark Plavsic

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AURA Aura Biosciences, Inc. Mar 15, 2024 0 $0 3 Mar 25, 2024 Chief Technology Officer
FATE FATE THERAPEUTICS INC Jan 10, 2023 1 -$17.9K 4 Jan 11, 2023 Chief Technical Officer
FATE FATE THERAPEUTICS INC Jul 5, 2022 1 -$91.5K 4 Jul 6, 2022 Chief Technical Officer
FATE FATE THERAPEUTICS INC Jan 25, 2022 2 $0 4 Jan 27, 2022 Chief Technical Officer
FATE FATE THERAPEUTICS INC Nov 19, 2021 1 $0 4 Nov 22, 2021 Chief Technical Officer
FATE FATE THERAPEUTICS INC Jun 14, 2021 2 $0 4 Jun 22, 2021 Chief Technical Officer
FATE FATE THERAPEUTICS INC Jun 14, 2021 0 $0 3 Jun 22, 2021 Chief Technical Officer